VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MLABMesa Laboratories, Inc.
$93.23$515M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMLABRevenue History

MLAB logoMesa Laboratories, Inc. (MLAB) Revenue History

Annual and quarterly revenue from 1990 to present

TTM Revenue$249.1M▲ +$0 vs FY2026
YoY Growth+2.6%Slow
Q4 2026$63.7M+2.6% YoY · -2.2% QoQ
Revenue CAGR
3Y+4.4%
→
5Y+13.2%
→
10Y+11.4%
Growth decelerating ↓
Best Fiscal Year$249.1M (2026)
Best Quarter$65.1M (Q3 2026)
Revenue per Share$45.09
Revenue per Employee$338K

MLAB Revenue Over Time (1990–2026)

MLAB Revenue Growth History

33 of 36 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
1990—
1991+25.0%
1992+8.6%
1993+15.8%
1994+40.9%
1995+6.5%
1996+22.7%
1997-3.7%
1998+1.3%
1999+2.5%
2000+6.9%
2001+5.1%
2002-0.6%
2003+0.4%
2004+0.5%
2005+10.0%
2006+15.4%
2007+48.9%
2008+13.4%
2009+10.1%
2010+1.8%
2011+49.7%
2012+20.7%
2013+17.2%
2014+13.5%
2015+35.3%
2016+18.7%
2017+10.6%
2018+2.7%
2019+7.2%
2020+14.1%
2021+13.8%
2022+37.6%
2023+18.8%
2024-1.3%
2025+11.5%
2026+3.4%
FY1990 revenue growth
N/A
FY1991 revenue growth
+25.0%
FY1992 revenue growth
+8.6%
FY1993 revenue growth
+15.8%
FY1994 revenue growth
+40.9%
FY1995 revenue growth
+6.5%
FY1996 revenue growth
+22.7%
FY1997 revenue growth
-3.7%
FY1998 revenue growth
+1.3%
FY1999 revenue growth
+2.5%
FY2000 revenue growth
+6.9%
FY2001 revenue growth
+5.1%
FY2002 revenue growth
-0.6%
FY2003 revenue growth
+0.4%
FY2004 revenue growth
+0.5%
FY2005 revenue growth
+10.0%
FY2006 revenue growth
+15.4%
FY2007 revenue growth
+48.9%
FY2008 revenue growth
+13.4%
FY2009 revenue growth
+10.1%
FY2010 revenue growth
+1.8%
FY2011 revenue growth
+49.7%
FY2012 revenue growth
+20.7%
FY2013 revenue growth
+17.2%
FY2014 revenue growth
+13.5%
FY2015 revenue growth
+35.3%
FY2016 revenue growth
+18.7%
FY2017 revenue growth
+10.6%
FY2018 revenue growth
+2.7%
FY2019 revenue growth
+7.2%
FY2020 revenue growth
+14.1%
FY2021 revenue growth
+13.8%
FY2022 revenue growth
+37.6%
FY2023 revenue growth
+18.8%
FY2024 revenue growth
-1.3%
FY2025 revenue growth
+11.5%
FY2026 revenue growth
+3.4%
DeclineStrong growth
↑ 2-year growth streakBest: +49.7% (FY2011)Worst: -3.7% (FY1997)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q4 2026$63.7M+2.6%
Q3 2026$65.1M+3.6%
Q2 2026$60.7M+5.0%
Q1 2026$59.5M+2.4%
Q4 2025$62.1M+5.5%
Q3 2025$62.8M+17.5%
Q2 2025$57.8M+8.8%
Q1 2025$58.2M+14.9%
Seasonal Revenue Pattern (fiscal quarters)
Q1
22%
Q2
24%
Q3
25%
Q4
28%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2026)

MLAB's revenue distribution by segment and geography for fiscal year 2026

By Product/Segment

Sterilization and Disinfection Control40.8%
Calibration Solutions21.5%
Biopharmaceutical Development19.5%
Clinical Genomics18.2%

By Geography

UNITED STATES46.9%
Other44.9%
CHINA8.2%

MLAB Revenue Analysis (1990–2026)

Current Revenue & Growth

As of June 23, 2026, Mesa Laboratories, Inc. (MLAB) generated trailing twelve-month (TTM) revenue of $249.1 million, reflecting modest growth of +2.6% year-over-year. The most recent quarter (Q4 2026) recorded $63.7 million in revenue, down 2.2% sequentially.

Historical Growth Trajectory

MLAB's 5-year compound annual growth rate (CAGR) stands at +13.2%, indicating consistent double-digit revenue growth. The 3-year CAGR of +4.4% is below the 5-year average, signalling a growth deceleration in recent years. Mesa Laboratories, Inc.'s highest annual revenue of $249.1 million was recorded in 2026, an all-time high.

Revenue by Segment

MLAB's revenue is primarily driven by Sterilization and Disinfection Control (41%), Calibration Solutions (21%), and Biopharmaceutical Development (20%). The diversified mix across segments reduces dependence on any single product line, which can support more resilient revenue in downturns.

Peer Comparison

Compared to Technology sector peers — including NEOG (-3.7% YoY), LFUS (+12.6% YoY), and NOVT (+5.6% YoY) — MLAB has underperformed the peer group in revenue growth. Compare MLAB vs NEOG →

MLAB Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
MLAB logoMLABCurrent$249M+2.6%+13.2%7.4%
NEOG logoNEOG$895M-3.7%+16.4%1.1%
LFUS logoLFUS$2.4B+12.6%+10.5%1.6%
NOVT logoNOVT$981M+5.6%+10.7%11.9%
RGEN logoRGEN$738M+17.4%+15.0%8.1%
TRMB logoTRMB$3.6B+3.2%+2.6%16.9%
Best in groupLowest in group

MLAB Historical Revenue Data (1990–2026)

1–15 of 37 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2026$249.1M+3.4%$158.3M63.5%$18.5M7.4%
2025$241.0M+11.5%$150.9M62.6%$16.3M6.8%
2024$216.2M-1.3%$133.3M61.6%$-272,075,000-125.9%
2023$219.1M+18.8%$133.7M61.0%$3.3M1.5%
2022$184.3M+37.6%$109.1M59.2%$4.7M2.6%
2021$133.9M+13.8%$87.0M65.0%$12.4M9.2%
2020$117.7M+14.1%$65.4M55.5%$7.9M6.7%
2019$103.1M+7.2%$60.9M59.1%$9.8M9.5%
2018$96.2M+2.7%$54.6M56.8%$2.2M2.3%
2017$93.7M+10.6%$53.2M56.8%$16.3M17.4%
2016$84.7M+18.7%$51.4M60.7%$16.3M19.3%
2015$71.3M+35.3%$43.4M60.8%$15.9M22.2%
2014$52.7M+13.5%$31.7M60.1%$11.8M22.4%
2013$46.4M+17.2%$28.9M62.2%$13.1M28.2%
2012$39.6M+20.7%$23.5M59.3%$12.5M31.5%
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

36+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MLAB — Frequently Asked Questions

Quick answers to the most common questions about buying MLAB stock.

Is MLAB's revenue growth accelerating or slowing?

MLAB revenue growth is slowing. TTM revenue is $249M, up +2.6% year-over-year — below the 5-year CAGR of +13.2%. The deceleration suggests maturing end-markets or increased competition.

What is MLAB's revenue history from 1990 to 2026?

Mesa Laboratories, Inc. (MLAB) revenue history spans 1990 to 2026. TTM revenue as of 2026 is $249M, growing at +2.6% YoY. The 5-year CAGR is +13.2%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is MLAB's long-term revenue growth rate (CAGR)?

Mesa Laboratories, Inc.'s 5-year revenue CAGR of +13.2% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +2.6% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for MLAB.

Why does MLAB's quarterly revenue fluctuate?

MLAB quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Mesa Laboratories, Inc.'s revenue data from 1990 to 2026 shows full historical quarterly detail on this page.

How is MLAB's revenue distributed by segment?

MLAB reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does MLAB's revenue compare to industry peers?

Mesa Laboratories, Inc. (MLAB) with TTM revenue of $249M and +2.6% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.